Welcome Letter From John

Welcome to the CIG website. We are glad that you found us, and trust that you will find the information presented useful, whether you are a newly diagnosed patient, or an experienced one. In the world of non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are often under represented. In order to gather more information, patients who have become affected by this blood disorder need to group together and become more “visible” and vocal in the medical community. As a collective group, we’ll be in a better position to raise CLL/SLL awareness and better request resources dedicated to our needs.

New This Month

North American Educational Forum on Lymphoma
On September 24-26, 2010, the Lymphoma Research Foundation will host its annual 2.5 day educational program for lymphoma patients, survivors and their loved ones.  The Forum will contain two CLL breakout sessions.  Register today!

Commitment to the CLL Community Award
John Balan and Richard Furman, MD honored for their commitment to CLL patient education. 

New CLL Publication Released - Download or Order Today
CIG is pleased to announce the availability of the first edition of Understanding CLL/SLL: A Guide for Patients, Survivors and Loved Ones.  Download the PDF or order a copy online. 

FDA Approves Rituximab (Rituxan) Plus Chemotherapy for CLL
Read about the FDA approval of rituximab (Rituxan) in combination with fludarabine and cyclophosphamide for patients with untreated or previously treated CD20-positive chronic lymphocytic leukemia.

New This Month Archive 

Subscribe to CLL/SLL Discussion Group

CIG is not a discussion group; it is a patient advocacy group that dispenses disease-specific information to people with CLL/SLL and their loved ones. However, we do have a related group where frequent and interesting discussions do take place. Richard Furman, MD, a CLL expert from Weill Medical College of Cornell University and New York-Presbyterian, is now active on this discussion group, so we have an important medical advisor on board. Subscribe to the discussion group today. 

Join CIG

To receive regular updates from us about new content, news, and upcoming programs and events, please Join CIG. 

back to top